{"id":"W4401327466","doi":"10.1200/jco.2024.42.16_suppl.7540","title":"Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Biotech","keywords":"Medicine; Refractory (planetary science); Multiple myeloma; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002044789,0.0001922722,0.001408186,0.000187964,0.00003588731,0.00001974744,0.0002659631,0.0003523135,0.0001954827],"category_scores_gemma":[0.00585751,0.00009702878,0.0005113531,0.0002549573,0.0003115484,0.0001706397,0.00007067474,0.001516728,0.00002612371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002342877,"about_ca_system_score_gemma":0.001823382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008568494,"about_ca_topic_score_gemma":0.0003167716,"domain_scores_codex":[0.995622,0.0006627658,0.002296542,0.0002764342,0.0008276348,0.0003146363],"domain_scores_gemma":[0.9905651,0.00741774,0.0009147181,0.0003588841,0.0003702144,0.0003733872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2689885,0.006704594,0.5010107,0.00002938633,0.0007545003,0.001628139,0.00009756653,6.177244e-7,0.00003546798,0.000004141637,0.0006273751,0.2201191],"study_design_scores_gemma":[0.3174778,0.0359708,0.6420155,0.0004438693,0.0003254843,0.00001677695,0.00003174963,0.00004170525,0.00003937303,0.00003581602,0.00353643,0.00006473728],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946755,0.0008496277,0.00004734495,0.001418279,0.001822805,0.0008315056,0.00005255365,0.00001116021,0.0002912507],"genre_scores_gemma":[0.9977676,0.0003300343,0.0004974034,0.0002120001,0.0008976225,0.00001336297,0.0000347835,0.00002891892,0.0002182585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2200543,"threshold_uncertainty_score":0.7012409,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09953379128334754,"score_gpt":0.455771068122289,"score_spread":0.3562372768389414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}